We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$283M
AUM Growth
+$162M
Cap. Flow
+$72.6M
Cap. Flow %
25.66%
Top 10 Hldgs %
42.53%
Holding
215
New
70
Increased
65
Reduced
14
Closed
66

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$2.38M
2
WMT icon
Walmart Inc
WMT
+$2.38M
3
JPM icon
JPMorgan Chase
JPM
+$2.13M
4
FATE icon
Fate Therapeutics
FATE
+$1.92M
5
FTNT icon
Fortinet
FTNT
+$1.5M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.05M
2
PFE icon
Pfizer
PFE
+$1.44M
3
CVS icon
CVS Health
CVS
+$1.41M
4
MET icon
MetLife
MET
+$1.4M
5
DE icon
Deere & Co
DE
+$1.24M

Sector Composition

Rank Sector Weight
1 Financials 18.71%
2 Technology 15.05%
3 Industrials 8.12%
4 Healthcare 7.38%
5 Energy 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$81.5B
$49.6M 17.54%
284,520
+1,020
+0.4% +$181K
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$44.4M 15.72%
116,219
+18,419
+19% +$7.08M
JPM icon
3
JPMorgan Chase
JPM
$937B
$5.16M 1.82%
38,454
+16,777
+77% +$2.13M
ADI icon
4
Analog Devices
ADI
$176B
$4.17M 1.47%
25,414
+4,971
+24% +$776K
WMT icon
5
Walmart Inc
WMT
$881B
$3.88M 1.37%
82,095
+50,082
+156% +$2.38M
MCD icon
6
McDonald's
MCD
$188B
$3.59M 1.27%
13,623
+9,028
+196% +$2.38M
AAPL icon
7
Apple
AAPL
$4.43T
$2.71M 0.96%
20,856
+7,416
+55% +$1.06M
MSFT icon
8
Microsoft
MSFT
$3.62T
$2.43M 0.86%
10,119
+5,311
+110% +$1.27M
SCHW
9
Charles Schwab
SCHW
$184B
$2.2M 0.78%
26,437
+6,609
+33% +$513K
BDX icon
10
Becton Dickinson
BDX
$46.9B
$2.08M 0.74%
8,180
+5,689
+228% +$1.34M
XOM icon
11
ExxonMobil
XOM
$643B
$2.03M 0.72%
18,374
-19,176
-51% -$2.05M
CSCO icon
12
Cisco
CSCO
$457B
$2.02M 0.71%
42,382
+23,214
+121% +$1.06M
CB icon
13
Chubb
CB
$134B
$1.95M 0.69%
8,824
+2,500
+40% +$520K
V icon
14
Visa
V
$683B
$1.94M 0.69%
9,336
-2,769
-23% -$558K
VZ icon
15
Verizon
VZ
$197B
$1.92M 0.68%
48,629
+30,821
+173% +$1.16M
PNC icon
16
PNC Financial Services
PNC
$100B
$1.89M 0.67%
11,938
+7,158
+150% +$1.13M
CVX icon
17
Chevron
CVX
$385B
$1.88M 0.67%
10,500
-6,100
-37% -$1.06M
COP icon
18
ConocoPhillips
COP
$145B
$1.86M 0.66%
15,732
+2,870
+22% +$349K
MRSH
19
Marsh
MRSH
$92B
$1.82M 0.64%
11,003
+7,047
+178% +$1.15M
BAC icon
20
Bank of America
BAC
$437B
$1.76M 0.62%
53,268
+33,964
+176% +$1.17M
NEE icon
21
NextEra Energy
NEE
$181B
$1.74M 0.61%
20,787
+5,405
+35% +$437K
LLY icon
22
Eli Lilly
LLY
$1,000B
$1.73M 0.61%
4,727
+1,103
+30% +$391K
ABBV icon
23
AbbVie
ABBV
$433B
$1.72M 0.61%
10,666
+1,458
+16% +$224K
MDLZ icon
24
Mondelez International
MDLZ
$78.8B
$1.72M 0.61%
25,763
+4,331
+20% +$274K
PEP icon
25
PepsiCo
PEP
$191B
$1.69M 0.6%
9,334
+2,345
+34% +$418K

Similar funds

Alpha DNA Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Alpha DNA Investment Management held 215 positions worth $283M, up 135% from $120M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management deployed $72.6M of net new capital in Q4 2022, opening 70 new positions and adding to 65 existing holdings. Its largest new stake was Fate Therapeutics: 102,094 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was ExxonMobil, an estimated $2.05M trimmed.

  • Alpha DNA Investment Management's largest Q4 2022 buy was Fate Therapeutics: 102,094 shares worth $1.03M.
  • Alpha DNA Investment Management added most to McDonald's in Q4 2022, an estimated $2.38M increase.
  • Alpha DNA Investment Management's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $2.05M.
  • Alpha DNA Investment Management fully exited CVS Health in Q4 2022, selling an estimated $1.41M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $283M portfolio in Q4 2022.
  • Alpha DNA Investment Management opened 70 new positions and closed 66 in Q4 2022.
  • Alpha DNA Investment Management's portfolio value rose 135% quarter-over-quarter to $283M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.